NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse is looking for a partner to start a center to handle the data from its genomic and molecular biology studies of drug addiction, abuse, and related psychiatric causes and implications, according to the National Institutes of Health.
NIDA seeks applicants to maintain a NIDA Center for Genetic Studies, which will process, generate, and distribute high-quality datafiles, documentation, and biological materials including DNA, RNA, cell lines, and serum. These data and materials will be collected from individuals with drug abuse and addiction-related disorders and their relatives.
NIDA seeks a contractor with experience in biospecimen processing, extraction, and dissemination, as well as experience preparing pedigree files and files used in statistical genetic analysis. The collaborator will be expected to work interactively with grantees funded by NIDA.
NIDA expects to fund a three-year contract with options for two additional years.
Applicants should be able to store over 35,000 existing samples and around 15,000 new samples, have an informatics component with a public, queriable interface, and must have personnel with expertise in psychiatric diseases.
Responses to an upcoming RFP will be due Dec. 22. More information is available here.